Aim of the study: To study the effect of topical phenytoin in healing of grade I and II diabetic 
I. Introduction
Wound healing is the process of restoration of physical integrity of internal or external body structures and involves complex interactions between the cells and various other factors 1 . Appropriate treatment and wound care accelerate the healing process and prevent infection and chronicity of the wound 2 . Despite extensive efforts to improve wound healing, the outcomes of existing methods are far from optimal 1 . Diabetic foot ulceration is estimated to occur in 5-10% of diabetic population 3 . Wound healing may be delayed due to abnormal cell function, hyperglycemia, peripheral neuropathy, peripheral vascular disease, susceptibility to infections and abnormal planter foot pressures, resulting in prolonged morbidity and even loss of part or whole of the foot 4 . The 5-5dipenyl 2-4 imidazolidione sodium, with generic name of Phenytoin, was synthesized in 1908 and is in clinical use as a potent anti-epileptic drug since 1937 5 . A frequently observed and unwanted side effect of phenytoin is gingival hyperplasia, especially in children 6 . In 1939, Kimball et al first observed that gingival hyperplasia occurred in some patients treated with phenytoin. This stimulated the study regarding the potential use of phenytoin in wound healing 7 .
There are studies and case reports about the use of topical phenytoin for a wide variety of soft tissue infections and ulcers 8 . This study was designed to determine the efficacy of topical phenytoin in the treatment of diabetic foot ulcers as topical use of phenytoin is not in routine use and different studies have shown conflicting results due to methodological flaws, such as inappropriate statistical analysis, inadequate control groups, and the absence of randomization and double-blinding 8 .
II. Material and methods
A total of one hundred patients with diabetic foot ulcers grade I and II were enrolled for the study after obtaining due clearance from the Institute Ethics Committee. Written informed consent was taken from every patient with adherence to the Principles of the Declaration of Helsinki. In group 1 fifty patients were dressed using crushed phenytoin tabletsmixed with normal saline and in group 2 fifty patients were dressed with normal Effect of topical phenytoin on wound healing DOI: 10.9790/0853-150902161164 www.iosrjournals.org 162 | Page saline. Patients were randomly allocated to a particular group by using computer generated random numbers. Sample size was calculated by using WHO calculator, level of significance was 5 % and power of test was 95%.Surgical debridement was done in both groups of patients as and when required. Pus culture was obtained and appropriate antibiotics were used as and when indicated. Ulcer size was measured by tracing the outline on a butter paper and transferred on graph paper and then taking the maximum diameter in two different areas perpendicular to each other. Wound healing was measured on Days 4, 8, 12, 16 and so on. Percentage of wound contracture was found by using the Walker formula 9 which is percentage of wound area= wound area on day x /wound area on day1 X 100. Percentage of wound healing= 100 -percentage of wound area. Dosage of phenytoin used was as given below: Size of ulcer in millimetre square -Dosage of phenytoin tablet in milligram 0-25 -100 >25-<50 -150 >50-< 75 -200
Efficacy was measured in terms of 50 % or more reduction in area of the ulcer and also the mean epithelisation time in days. Statistical analysis was done using the SPSS version 22 for Windows, Inc Chicago II.Descriptive statistics was used to find the mean± standard deviation.Mann Whitney test was done to find the difference between the various variables in the two groups. Patients with history of hepatic and renal disease, those on steroid use and those with impalpable dorsalis pedis or posterior tibial arteries were excluded.
III. Results
Patient profile is shown in Table 1 . There was significant difference in the rate of healing between the two groups (P value <0.05) with the patients in group 1 healing much earlier than those in group 2 as shown in table 2. Pearson correlation was found between the two groups and group 1 showed significant difference (P<0.05) than group 2. There was no significant difference in the rate of healing depending on the grade of ulcer as shown in table 3. Table 4 showed significant difference (P <0.05) in the rate of 50% wound contracture in the size of the ulcers. 
IV. Discussion
Shapiro carried out the first clinical trial in 1958 and found out that periodontal patients with surgical wounds who were pre-treated with oral phenytoin had less inflammation, less pain, and accelerated healing as compared to controls 10 . Its wound healing promoting effect has been attributed to many mechanisms including increasing fibroblast proliferation, inhibiting collagenase activity, promoting collagen deposition, enhancing granulation tissue formation, decreasing bacterial contamination, reducing wound exudates formation and up regulating growth factor receptors 11 . Biopsies of Phenytoin treated wounds show neovascularization, collagenization and decreased polymorphnuclear and eosinophil cell infiltration 12 . Topical application of phenytoin results in direct access of the drug to the target site and avoids the risk of getting systemic side effects 13 . The beneficial effect of phenytoin has also been shown in promoting healing of decubitus ulcers 14 , venous stasis ulcers 15 , traumatic wounds 16 , burns 17 , and leprosy trophic ulcers 18 . Crushed phenytoin tablet was used for topical application as was done by Rhodes et al 19 in their study. Only patients with grades I and II were included in the study to deal with problems of wounds with undermined margins and alsoarea measurements in deeper wounds is fallacious as they start the healing process from the base of the woundby building up granulation tissue.
Effect of topical phenytoin on wound healing
Shaw et al 3 in 2007 in their meta-analysis of 14 trials of phenytoin on wound healing,found positive percentage treatment effect in favor of the phenytoin-treated group in one study investigating diabetic foot wounds and one study on chronic wounds but there was limited evidence for the use of phenytoin in burns and war wounds. Muthukumarasamy et al 20 demonstrated ulcers treated with topical phenytoin healed more rapidly with mean time to complete healing was 21 days as against 45 days in the control(p< 0.05).Similar results were reported by Tauro et al 21 where wound area reduction and bacterial clearance was greater in the phenytoin group than in controls. El-Nahas et al 22 demonstrated that topical phenytoin significantly improved healing of recalcitrant neuropathic diabetic foot ulcers. Carneiro et al 23 also reported significant reduction in pain, clearance of ulcer discharge, early formation of healthy granulation tissue with phenytoin dressing while comparing to EUSOL dressing(p < 0.05), however bacterial colonization clearance was not statistically different between the two groups.
Even with all the positive data available, the role of topical phenytoin in the wound healing process is still controversial and efficacy is doubted due to the lack of multicentric, double blind nature of the earlier studies 24 . Shaw J et al in their studies concluded that there was nosignificant difference in ulcer closure rates between those with phenytoin dressing and control dressing and hence did not support the use of topical phenytoin in the treatment of diabetic foot ulcers 25 . Pai et al 26 also demonstrated no significant difference in the mean percentage reduction of ulcer area in the phenytoin vs. control group (78.3% vs. 73.5% with P > 0.05) in their double blind controlled trial on the effectiveness of phenytoin in diabetic neuropathic ulcers, Our study showed marked shortening in the mean epithelisation time and also hastened the rate of ulcer contraction after applying crushed phenytoin tablets to the ulcers.However further research is required to establish phenytoin as healing agent 22, 26 . Conclusion: Topical application of phenytoin in the powder form definitely helps in early healing of diabetic foot ulcers which is cheap and readily available.
